Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-005608
Filing Date
2025-04-28
Accepted
2025-04-28 06:03:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A qure-20250611xdefa14a.htm DEFA14A 17054
2 GRAPHIC qure-20250611xdefa14a_bg001.jpg GRAPHIC 164091
3 GRAPHIC qure-20250611xdefa14a_bg002.jpg GRAPHIC 165473
  Complete submission text file 0001558370-25-005608.txt   472338
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36294 | Film No.: 25875822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)